BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7790997)

  • 21. [AgNORs as an alternative to Ki67on paraffin-embedded material in breast carcinoma].
    Oddi G; Visca P; Parisi AM
    Pathologica; 1992; 84(1094):75-8. PubMed ID: 1300535
    [No Abstract]   [Full Text] [Related]  

  • 22. Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma.
    Griffiths AP; Butler CW; Roberts P; Dixon MF; Quirke P
    J Pathol; 1989 Oct; 159(2):121-7. PubMed ID: 2478686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification.
    Jakić-Razumović J; Petrovecki M; Dominis M
    Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nucleolus organizer regions in prostatic intraepithelial neoplasm].
    Sentinelli S; Rondanelli E
    Pathologica; 1990; 82(1080):405-12. PubMed ID: 2284142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A standardized AgNOR stain method for formalin fixed and paraffin embedded material].
    Ofner D; Bankfalvi A; Riehemann K; Böcker W; Schmid KW
    Pathologe; 1994 Aug; 15(4):226-30. PubMed ID: 7971797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
    Pich A; Chiarle R; Chiusa L; Palestro G
    Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlationship between cellular DNA and AgNOR protein content in the developing course of colorectal adenocarcinoma].
    Qu HT; Xie Y; Chen XL
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):192-5. PubMed ID: 7956697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
    Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
    Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification.
    Trerè D; Migaldi M; Trentini GP
    Anal Cell Pathol; 1995 Jan; 8(1):57-65. PubMed ID: 7734412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and assessment of nucleolar organizer regions (NORs)--technical problems.
    Zaczek M; Dabroś E; Maciejowski J; Szot W
    Pol J Pathol; 1994; 45(1):35-8. PubMed ID: 7513845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multilabeling technique for simultaneous demonstration and quantitation of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue.
    Munakata S; Hendricks JB
    J Histochem Cytochem; 1994 Jun; 42(6):789-3. PubMed ID: 7514625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [AgNOR in neurooncology].
    Martin H; Gottschalk J; Hufnagl P; Beil M
    Acta Histochem Suppl; 1992; 42():179-84. PubMed ID: 1584963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric carcinoma: histopathology, immunocytochemistry and variations of nucleolar organizer regions (AgNORs).
    Bufo P; Frassanito F; Maiorano E
    Boll Soc Ital Biol Sper; 1991 Jul; 67(7):707-13. PubMed ID: 1840172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technical and methodological aspects of silver staining and measurement of nucleolar organizer region (NOR).
    Trerè D
    Zentralbl Pathol; 1994 Mar; 140(1):11-4. PubMed ID: 7515668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Outcome of patients with primary malignant lymphoma of the brain; relationship to the nucleolar organizer region].
    Nakasu S; Nakazawa T; Saito A; Matsuda M; Handa J
    No Shinkei Geka; 1992 May; 20(5):593-8. PubMed ID: 1598135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival of thymoma patients by histologic pattern and proliferative activity.
    Pich A; Chiarle R; Chiusa L; Ponti R; Geuna M; Casadio C; Maggi G; Palestro G
    Am J Surg Pathol; 1995 Aug; 19(8):918-26. PubMed ID: 7611538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Argyrophilic nucleolar organizer regions and proliferating cell nuclear antigen/cyclin in Kaposi's sarcoma. Comparison with morphology and with immunoperoxidase staining for factor VIII-related antigen.
    Haupt HM; Stern JB; Multhaupt H; Newman HW
    Arch Pathol Lab Med; 1995 Jun; 119(6):538-41. PubMed ID: 7605171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
    Aubele M; Auer G; Jütting U; Falkmer U; Gais P
    Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of three different AgNOR counting methods in advanced carcinoma of the prostate.
    Ahiskali R; Alican Y; Ekicioğlu G; Cevik I; Küllü S; Akdaş A
    Prostate; 1995 Feb; 26(2):105-10. PubMed ID: 7531845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma.
    Pich A; Valente G; Azzoni L; Stramignoni A; Margaria E; Tasso M
    Pathol Res Pract; 1991 May; 187(4):482-6. PubMed ID: 1715079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.